Showing results (421-430 of 455) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2025
Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell LymphomaRichard T Maziarz, Michael R Bishop, Constantine S Tam, et al.
British Journal of Haematology|July 9, 2013
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvementRichard T Maziarz, Zhiwei Wang, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2015
New cancers after autotransplantations for multiple myelomaAnuj Mahindra, Girindra Raval, Paulette Mehta, et al.
Blood Advances|April 25, 2018
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2013
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation researchJames M Foran, Steven Z Pavletic, Brent R Logan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2023
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401David J Chung, Nina Shah, Juan Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2017
Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for ProphylaxisMuna Qayed, Tao Wang, Michael T Hemmer, et al.
Blood Advances|July 30, 2026
Regional practice differences significantly impact benefit from post-HCT gilteritinib for FLT3-ITD AMLMark J Levis, Mehdi Hamadani, Brent R Logan, et al.
Blood|January 8, 2025
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AMLMark J Levis, Mehdi Hamadani, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 26, 2016
Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell TransplantationKaren Ballen, Kwang Woo Ahn, Min Chen, et al.
Pageof 46